Back to results
US 12,668,799 B2Granted
Non-liposomal systems for nucleic acid delivery
AssigneeArbutus Biopharma Corporation
InventorsEd Yaworski, Lloyd B. Jeffs, Lorne R. Palmer
Life of this patent
Estimating the term…
Abstract
The present invention provides novel, stable lipid particles having a non-lamellar structure and comprising one or more active agents or therapeutic agents, methods of making such lipid particles, and methods of delivering and/or administering such lipid particles. More particularly, the present invention provides stable nucleic acid-lipid particles (SNALP) that have a non-lamellar structure and that comprise a nucleic acid (such as one or more interfering RNA), methods of making the SNALP, and methods of delivering and/or administering the SNALP.
Claims33
A composition comprising:
- a plurality of nucleic acid-lipid particles, wherein each particle in the plurality of particles comprises:
- (a) a nucleic acid;
- (b) a titratable cationic lipid comprising three or more fatty acid or fatty alkyl chains;
- (c) a non-cationic lipid;
- and
- (d) a conjugated lipid that inhibits aggregation of particles,
- wherein at least about 95% of the particles in the plurality of particles are electron-dense.
4 more elements
Dependencies are inferred from the claim text.